Writing groups are a team of research investigators who support a lead author in the development of their manuscript by:
Paper proposals recently approved by the P&P Committee become open to accept nominations for writing group members. Since active participation is expected of every writing group member, members should be conscious of the number of groups they choose to participate in and keep their number of nominations to a reasonable limit.
If a title among the list of open writing groups interests you, please feel free to email the P&P Committee to obtain more information or provide you with a contact to the lead author.
Ms4394 – Association of diet quality on risk of incident rheumatoid arthritis and cardiovascular disease in the Women’s Health Initiative – Kanika Malani
Ms4419 – Cohort profile: The Women’s Health Accelerometry Collaboration – Kelly EvensonOnly investigators from centers that participated in Ancillary Study 286 are eligible for this writing group
Ms4420 – Biomarkers of radiation-induced cardiovascular disease in breast cancer – Alexi Vasbinder
Ms4421 – A longitudinal cohort study of sleep and leukemia incidence among postmenopausal women – Shang Hui
Ms4422 – Psychosocial stress and risk of triple-negative breast cancer – Juhua Luo
Ms4423 – Variable selection with FDR control for noisy data – with application to screening metabolite that are associated with breast and colorectal cancer – Ran Dai
Ms4424 – Psychometric analysis of positive affect and optimism among community-living older women: Women’s Health Initiative Study – Alexander Posis
Ms4427 – Disentangling genetics of extreme longevity using polygenic risk scores – Sven Vanderlee
The following proposals stem from a consortium; writing group slots for WHI investigators may be limited
Ms4433 – Methylation patterns associated with lifestyle factors (smoking, alcohol, and physical activity) and reproductive traits in PAGE multi-ethnic populations – Lani Park
Ms4434 – Role of single nucleotide polymorphisms in the association between apolipoprotein L1 renal risk variants and renal outcomes – Girish Nadkarni
The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services.
© 2021 Women’s Health Initiative. All rights reserved